IP Library › Granted Patent US 9,708,328
Granted Patent B2
US 9,708,328 · App. 15/047,038 · Granted Jul 18, 2017

Pteridines useful as HCV inhibitors and methods for the preparation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,708,328
App. No.
15/047,038
Granted
Jul 18, 2017
Kind
B2
Abstract

The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents.

Claims (14)

1. A compound of the formula (VII):

or a salt, stereoisomeric form, or racemic mixture thereof, wherein

R 1 is hydrogen;

R 8 is hydrogen and R 9 is —CONR 4a R 4b ;

or

R 8 is phenylC 1-4 alkyl and R 9 is hydrogen;

R 4a is hydrogen;

and R 4b is 2-oxo-pyrrolidin-1-yl-C 1-4 alkyl.

2. The compound according to claim 1 of the formula (VIII):

3. The compound according to claim 2 , wherein R 8 is phenylC 1-4 alkyl and R 9 is hydrogen.

4. The compound according to claim 1 that is

5. The compound according to claim 1 that is

6. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable excipient.

7. The pharmaceutical composition according to claim 6 , further comprising one or more other anti-hepatitis C virus agents.

Assignments (1)
CHANGE OF NAME Recorded Jul 27, 2022
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 060989/0661 →